Laddar...

Stem-cell transplantation in multiple myeloma: how far have we come?

High-dose therapy (HDT) and autologous stem-cell transplantation (ASCT) has historically been an essential part of multiple myeloma (MM) management since early studies demonstrated its efficacy in relapsed disease, and subsequent phase III trials demonstrated better responses and improved survival w...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Ther Adv Hematol
Huvudupphovsmän: Soekojo, Cinnie Y., Kumar, Shaji K.
Materialtyp: Artigo
Språk:Inglês
Publicerad: SAGE Publications 2019
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6859676/
https://ncbi.nlm.nih.gov/pubmed/31798820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620719888111
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!